Research Site US032 — Nampa, Idaho

Research Site US032 is a clinical research site located in Nampa, Idaho, United States 83687.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site US032 has participated in 1 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus Infections.

Sponsors: Novavax.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nampa

Browse all research sites in Idaho · View every site in Nampa

• Saint Luke's Cancer Institute - Nampa
• Saint Alphonsus Cancer Care Center-Nampa
• Saint Alphonsus Medical Center Nampa
• Saint Luke's Mountain States Tumor Institute - Nampa
• GSK Investigational Site
• ASR,LLC
• Saltzer Medical Group
• Research Site
• Saint Luke's Mountain States Tumor Institute
• Saltzer Health
• Saltzer Medical Group Research
• Novo Nordisk Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site US032?

Research Site US032 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site US032 conducted?

Research Site US032 has 1 clinical trials on record. Their work covers Respiratory Syncytial Virus Infections.

Is Research Site US032 accredited by Crixeo Clinical Trials?

Research Site US032 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site US032?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.